Bloomberg reported that Baxter is exploring options to divest its renal care services and hemodialysis businesses to focus more resources on higher-growth businesses and pay down the debt it took on to acquire Hillrom last year.
Baxter may divest two parts of its renal care division, Bloomberg reported based on conversations with undisclosed sources close to the company.
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.
While Roche continues to view China as a strategic growth market, a sharp 23% decline in Chinese diagnostics sales offset gains in other regions and segments. Despite near-term headwinds, Roche is betting on strong instrument placement growth across its Core Lab, Molecular, and Near Patient Care segments to fuel future demand for consumables and services–key components of its long-term medtech strategy.
New continuous glucose monitoring manufacturing site in Indiana is part of Roche’s plan to boost its US presence. Roche’s launch of Accu-Chek SmartGuide system last year with AI-powered prediction capabilities puts it as a key differentiator from competitors such as Abbott and Dexcom.
